These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11758998)

  • 21. Derivation and validation of toxicophores for mutagenicity prediction.
    Kazius J; McGuire R; Bursi R
    J Med Chem; 2005 Jan; 48(1):312-20. PubMed ID: 15634026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the structural requirements for mutagenicity by incorporating molecular flexibility and metabolic activation of chemicals I: TA100 model.
    Mekenyan O; Dimitrov S; Serafimova R; Thompson E; Kotov S; Dimitrova N; Walker JD
    Chem Res Toxicol; 2004 Jun; 17(6):753-66. PubMed ID: 15206896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model.
    Serafimova R; Todorov M; Pavlov T; Kotov S; Jacob E; Aptula A; Mekenyan O
    Chem Res Toxicol; 2007 Apr; 20(4):662-76. PubMed ID: 17381132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagens in surface waters: a review.
    Ohe T; Watanabe T; Wakabayashi K
    Mutat Res; 2004 Nov; 567(2-3):109-49. PubMed ID: 15572284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR modeling for predicting mutagenic toxicity of diverse chemicals for regulatory purposes.
    Basant N; Gupta S
    Environ Sci Pollut Res Int; 2017 Jun; 24(16):14430-14444. PubMed ID: 28435990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially mutagenic impurities: analysis of structural classes and carcinogenic potencies of chemical intermediates in pharmaceutical syntheses supports alternative methods to the default TTC for calculating safe levels of impurities.
    Galloway SM; Vijayaraj Reddy M; McGettigan K; Gealy R; Bercu J
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):326-35. PubMed ID: 23688841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards quantitative read across: Prediction of Ames mutagenicity in a large database.
    Benigni R
    Regul Toxicol Pharmacol; 2019 Nov; 108():104434. PubMed ID: 31374229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Ames Mutagenicity Using Conformal Prediction in the Ames/QSAR International Challenge Project.
    Norinder U; Ahlberg E; Carlsson L
    Mutagenesis; 2019 Mar; 34(1):33-40. PubMed ID: 30541036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reaction mechanism-based prediction of mutagenicity: α-halo carbonyl compounds adduct with DNA by S
    Haranosono Y; Ueoka H; Kito G; Nemoto S; Kurata M; Sakaki H
    J Toxicol Sci; 2018; 43(3):203-211. PubMed ID: 29540654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel pathway to the ultimate mutagens of aromatic amino and nitro compounds.
    Wild D
    Environ Health Perspect; 1990 Aug; 88():27-31. PubMed ID: 2272323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenic nitrenes/nitrenium ions from azido-imidazoarenes and their structure-activity relationships.
    Wild D; Dirr A
    Mutagenesis; 1989 Nov; 4(6):446-52. PubMed ID: 2695757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Salmonella mutagenicity.
    Zeiger E; Ashby J; Bakale G; Enslein K; Klopman G; Rosenkranz HS
    Mutagenesis; 1996 Sep; 11(5):471-84. PubMed ID: 8921509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity of chemicals added to foods.
    Zeiger E
    Mutat Res; 1993 Nov; 290(1):53-61. PubMed ID: 7694099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary phenolics as anti-mutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers.
    Malaveille C; Hautefeuille A; Pignatelli B; Talaska G; Vineis P; Bartsch H
    Carcinogenesis; 1996 Oct; 17(10):2193-200. PubMed ID: 8895488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical and biological factors affecting mutagen potency.
    Colvin ME; Hatch FT; Felton JS
    Mutat Res; 1998 May; 400(1-2):479-92. PubMed ID: 9685706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
    Tennant RW
    Environ Health Perspect; 1991 Dec; 96():47-51. PubMed ID: 1820276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.